[ORGANIZATION]
Johnson & Johnson
Featured in 59 tracked stories · first seen
Situations
Germany pension, social welfare & care reform updates
235 clusters · 535 sources · last updated
Latest: Germany pension system: Changes to contributions and benefits for 2027
Germany continues to navigate extensive social security and pension reforms amid demographic shifts and political friction. Significant welfare changes took effect on July 1, 2026, as the ‘Bürgergeld’ was replaced by a n
US Social Security: 2027 COLA and Solvency Projections
102 clusters · 229 sources · last updated
Latest: Social Security Administration announces 3.6% COLA for 2027
The Social Security Administration is transitioning to full electronic benefit delivery by the end of 2026. The Old-Age and Survivors Insurance (OASI) trust fund faces imminent insolvency, with projections suggesting ful
Expanding research and economic scale of menopause care
18 clusters · 72 sources · last updated
Latest: Misinterpretation of hormone data and clinical gaps impact menopause care
Medical research and management strategies for menopause are expanding to include neurological, biological, and holistic perspectives. Recent studies emphasize that menopause symptoms—including insomnia, memory issues, a
Perimenopause health: metabolic, cardiovascular, and brain
39 clusters · 114 sources · last updated
Latest: Iatrogenic menopause linked to increased cardiovascular risks
Research continues to link perimenopausal hormonal shifts to diverse metabolic, musculoskeletal, and sexual changes. Declining estrogen and fluctuating progesterone, testosterone, cortisol, and thyroid hormones disrupt h
Clinical applications and access of CAR-T and myeloma cell/m
19 clusters · 69 sources · last updated
Latest: CAR-T and CAR-NK therapies show clinical progress in autoimmune and cancer treatments
CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant
Oil prices surge amid Middle East tensions and supply risks
6 clusters · 228 sources · last updated
Latest: Saudi stock market rebounds amid oil price shifts and geopolitical tensions
Global oil prices remain volatile as geopolitical instability in the Middle East and weather threats in the United States drive market fluctuations. Brent crude has recently moved around the $100 to $101 per barrel mark.
Guselkumab reimbursement approval in Italy
2 clusters · 13 sources · last updated
Latest: Italy approves reimbursement for Guselkumab for bowel diseases
Italy has approved reimbursement for the Johnson & Johnson drug guselkumab (Tremfya) to treat two specific inflammatory bowel diseases: moderate to severe active ulcerative colitis and moderate to severe active Crohn’s d
PepsiCo revises earnings guidance downward
5 clusters · 28 sources · last updated
Latest: PepsiCo reports revenue growth despite North American volume declines
PepsiCo reported third-quarter 2026 net revenues of $25.27 billion, a 5.6 percent increase from $23.94 billion the previous year. While organic growth reached 3.1 percent, the company continues to face significant challe
Icotrokinra clinical trial results for psoriasis
2 clusters · 5 sources · last updated
Latest: Johnson & Johnson reports long-term efficacy for oral psoriasis drug Icotyde
Johnson & Johnson has released long-term Phase 3 clinical trial data for icotrokinra (Icotyde), an oral peptide designed to treat moderate-to-severe plaque psoriasis by blocking the interleukin (IL)-23 receptor. Data fr
South Korean medical adoption of Pulsed Field Ablation
3 clusters · 5 sources · last updated
Latest: Sejong Chungnam National University Hospital reaches 100 PFA ablation cases
South Korean medical institutions are achieving significant milestones in the use of Pulsed Field Ablation (PFA) to treat atrial fibrillation. This modern technique utilizes short, high-voltage electrical pulses to targe
Global robotics expansion: Industrial, consumer, and Middle-
13 clusters · 65 sources · last updated
Latest: Robotics firms expand international presence in Brazil and Portugal
The robotics sector is transitioning from technical demonstrations to practical deployment across retail, healthcare, and industrial sectors. While early developments focused on specific applications—such as surgical ins
AstraZeneca regulatory and portfolio developments
3 clusters · 5 sources · last updated
Latest: AstraZeneca and Johnson & Johnson advance new cancer treatments
AstraZeneca has achieved several regulatory milestones regarding its oncology and rare disease pipelines. In Europe, the company received approval for Enhertu in combination with pertuzumab for first-line treatment of HE
Also covered in
-
Johnson & Johnson and Smith & Nephew merger fails over CEO dispute
[BUSINESS] · 2 sources ·
-
Johnson & Johnson faces legal scrutiny over talcum powder and ovarian cancer
[HEALTH] · 4 sources ·
-
Johnson & Johnson focuses on biopharma and medtech for growth
[BUSINESS] · 2 sources ·
-
OmniAb outlines royalty strategy and new peptide discovery platform
[BUSINESS] · 2 sources ·
-
Dublin health conferences address life sciences and service integration
[HEALTH] · 2 sources ·
-
Param Hospital installs new robotic surgical system in Surat
[HEALTH] · 2 sources ·
-
Yuhan Corporation celebrates 100 years and Lazertinib success
[BUSINESS] · 4 sources ·
-
Contineum depression drug fails mid-stage clinical trial
[BUSINESS] · 2 sources ·
-
David Ferrera expands medical device ventures into Middle East and Africa
[BUSINESS] · 2 sources ·
-
Natalia Oreiro reflects on career origins and motherhood
[CULTURE] · 2 sources ·